Home
第28回 治験審査委員会・会議記録 - 名古屋大学医学部附属病院 先端
Contents
1. b c d g lt 5 2 gt NG x C
2. 7 b ES 2 a 3 lt 6 P 15 8 3 3 P 23 gt HIV FF 7
3. 2013 4 26 230035 MP 424 C Genotype2 2b 1 2013 4 22 8 EO MP 424 C Genotype2 2b 1 2013 4 22
4. 6 1 230015 CRFBO02E2301 2012 10 10 5 dH 29 Eg
5. 2013 4 12 7 17 TKI258
6. 1 13 17 13 1 IF 0 S
7. 2013 4 11 240036 3 CIDP FTY720 2013 4 25 240039 C Asunaprevir BMS 650032 Daclatasvir BMS 790052 2013 4 26 240042 MP 424 C
8. 230007 B NNC 0156 0000 0009 N9 GP 230037 1 230051 B
9. 2013 4 4 220011 2 2013 4 4 220011 3 2013 4 16 220012 1 2013 4 4 220012 2 20
10. 1 232001 I EGFR 2019 3 7 27 2013 4 12 232002 TAP 144 SR 3M T LL 2013 3 7 27 2013 4 30
11. CVJ 12 01 2013 4 26 240032 1b C Asunaprevir Daclatasvir 3 2013 4 26 240033 1 DMARD CNT0136
12. 2013 4 15 230024 1 2013 4 24 230027 1 AMG 162 I 2013 4 10 AMG 162 230027 2 ER II 2013 4 18 230027 3 ED AMG 162 2013 4 24 230034 1 2013 4 26
13. PNRD 2 17 g 230042 1 2 CD 200027 1 2013 4 26 200029 2 CDP870 MTX 200030 2 210008 210026 1 2013 5 15 H GVHD 2013 5 7 lt JR 031 111 CD20 C2B8 2013 4 4 CD20 200027 2 C2B8 2013 4 16 5 17
14. 1 2013 4 26 220026 A oo N8 wd ll 4 17 220036 1 2013 4
15. 2013 4 26 240003 von Willebrand rVWF rFI rVWF 2013 4 30 240004 230052 2 VEGF mTOR gt II 2013 4 26 240005
16. 2013 4 25 240018 1 ASPO15K II TL 2013 4 11 240018 2 ASPO15K IL 2013 4 18 L 240019 1 ASP015K 2013 4 11 240019 2 ASP015K I TI 2013 4 18 240021
17. 230037 1 I 2013 4 12 230037 2 1 6 17 1 2013 4 26 230038 1 EE NC224 L 2013 4 12 230038 2 INC224 L 2013 4 26 230039 1
18. 2013 4 25 UN 240015 2 ME 240016 OPC 14597 2013 4 25 240017 OPC 14597 2
19. E E 2E7 II FE 2013 4 15 2013 4 2 3 17 CP 690 550 EF 210026 2 CP 690 550 2013 4 16
20. 230048 1 cabazitaxe1 CD ee 1 2013 4 10 230048 2 lt cabazitaxeL CD ER 2013 4 25 230049 1b C BMS 790052 BMS 650032 3 2013 4 26 230052 1 VEGE mTOR TKI258
21. 7 1 CD E 5 210034 2 a fF E Ek e b c d 2013 5 2 5 17
22. 2013 4 30 SOM230LAR BIBF1120 240030 1 9 17 EE EE rr II 2013 4 10 240030 2 a SAR302503 TL 2013 4 25 Me E IS 240031
23. 230034 2 CDP870 0PB 51602 CDP870 TI
24. 2013 4 10 240033 2 DMARD CNT0136 2013 4 25 240034 1 TNF a CNTO136 2013 4 10 240034 2 TNF a CNTO136 2013 4 25
25. 230043 1 DTC E7080 3 2013 4 30 230045 1 2 TAK 87 2 MM 2013 4 4 230045 2 2 NS 2013 4 18 230045 3 2 TAK 87 2 2013 4 25
26. TH IDEC IDEC CDP870 MTX 275 08 001 E CDP870 MTX 275 08 001 2013 4 26 200030 1 CDP870 MTX CDP870 MTX 1 CDP870 MTX
27. MC710 2013 4 3 MC710 ML IL 230046 KW 3357 2013 4 16 KW 3357 DIC DIC KW 3357 230029 MK 7009 2013 4 17 C MK 7009 7zn 2b MSD 230025 NPB 01 2013 4 25 16 17 NPB 01
28. 230015 1 P2 URL URL http www nu camcr org cms ctc public giji 12 17
29. 240042 MP 4240C 1 240045 2 243001 SUN Y7017 Me HH O1 2 2 4 TV
30. IgPro20 CGL 2013 4 4 230039 2 IgPro20 CGCL 2013 4 17 230039 3 IgPro20 CGCL 2013 4 30 230042 GVHD JR 031 TI TL 2013 4 9
31. URL http www med nagoya u ac jp cctcr ctc public giji html 2013 5 22 lt i gt MS
32. 232003 Crow Fukase POEMS lt FPP300 2013 4 26 232002 TAP 144 SR 3M IL LIL 2013 4 30 213001 Ph CML CP TV 2013 4 22 9
33. 2 AN 52 2013 4 30 230022 1 2013 4 5 230022 2 5 17 EE 2013 4 19 230022 3 2013 4 26 230023 ERR secukinumab NH
34. I 200001 E0302 200002 E0302 200027 IDEC C2B8 210008 D2E7 210013 SPP100 210026 CP 690 550 10 210034 BAY43 9006 213001 AMN107 220024 BIBW2992 222001 FPF300 230005 NN7999 230006 NN7999 230010 GSK1605786A 230013 BAY86 5321 230013 BAY86 5321 230017 MK 7009 230017 MK 7009 230017 MK 7009 230019 SAR245408 230019 SAR245408 230020 NPB 01 230022 a 230022 EE 230023 AIN457 230024 OPB 51602 230025 MK 7009 230026 DE 102 230027 AMG162 230030 KW 3357 230030 KW 3357
35. HER2 a e f 4 P 13 a d f 1 e 3
36. g TV gt c d IV gt 3 4 3 lt 6 2 P 18 20 6 7 8 gt 1 6 P 20 lt 6 b HER2
37. 240012 E 1 2013 4 19 240013 1 NIK 333 NIK 330 C ei q 10 g 8 17 240013 2 NIK 333 NIK 333 0 Mi 1 30 MX
38. 1 gs 200029 1 CDP870 MTX CDP870 MTX indolent B L indolent B L I 1
39. 230020 3 3 1 CDP870 2012 12 25 CDP870 MTX 200019 CDP870 2012 12 25 CDP870 MTX 200020 MRA SC 2013 3 25 MRA SC 220007 AMG162 2013 3 25 AMG162 denosumab 200012 E2080 2013 3 25 E2080 220022 E2080 2013 3 25 E2080 220023 17 17 df df Q dD df
40. 1 1 16 2013 4 25 240008 1 K 134 LIL 2013 4 11 240008 2 K 134 LIL 2013 4 30 240009 1 TAP 144 SR 6M
41. 240035 1 ER 2013 4 19 240035 2 2013 4 26 1 I 240036 1 CIDP FTY720 2013 4 4 240036 2 CIDP FTY720
42. BI6727 1 2013 4 26 240022 1 I I le 0 MSN SOM230LAR 2013 4 19 240022 2 II BIBF1120 2013 4 26 240028 1 IPF 2013 4 15 240028 2 IPF
43. 10 17 2013 4 22 240043 DSP 1747 0 2 II 2013 4 17 222001 Crow Fukase POEMS FPF300 TL 2013 4 26
44. A MO PD 5 1 2
45. d e b c ee a PGI 5 PE 5 gt lt 5 5 a EE 3 a CD E d E 253001 1 220001
46. 210034 1 7 IF7 7 LL 2013 4 10 210034 2 I 7 77F7 7 L H 2013 4 24 220003 1 L059 2 dN E 2013 4 12 220003 2 L059 2 eds E 2013 4 26 220011 1
47. 230037 ES 230037 PE 14 17 GIF E AH S MM A I F 230038 INC424 230040 GSK548470 230041 GSK548470 230042 JR 031 230043 E7080 230044 MCI 186 HP 230044 MCI 186 MM 230045 TAK 875 A Cabazitaxel yy
48. IF E QQ 0 I Mh 240017 OPC 14597 240018 ASPO15K 240019 ASP015K 240022 SOM230LAR I 240023 DSP 5423 240023 DSP 5423 240024 DSP 5423 240024 DSP 5423 240030 SAR302503 240032 i 240033 CNT0136 240034 CNT0136 240035 BGJ398 240035 BGJ398 240036 FTY720 240037 ACT 064992 240041 ON0 2745 240042 MP 424 240043 DSP 1747 IE 250001 UF 021 240031 CVJ 12 01 232002 TAP 144 SR 3M 2
49. Lv lt EE 3 EE 2013 4 3 240009 2 TAP 144 SR 6M EE ki 2 EE 3 EE 2013 4 17 240009 3 TAP 144 SR 6M EE 3 lt EE 3 2013 4 24 240010 AJM300 2 I 2013 4 23 240011 AK160 2013 4 17
50. P 4 gt 0 b 250009 BAY q6256 iloprost 3 250008 aE b 6 P
51. 28 2013 5 20 16 00 18 35 8 I 27 2013 4 22 II 1 2013 5 5 250007 mm LI ES IT 250008 UL 3 i LY300910 RE
52. 11 220036 2 2013 4 25 220040 1 CDP870 2013 4 26 220040 2 2013 4 26 230010 2013 4 26 CDP870 ij 0 2013 4 10 230011 GSK1605786A 3 2013 4 10 2013 4 10 230013 1 ME
53. CSL654 IL CSL IT rIX FP 0 IMP 230055 FI NNC 0129 0000 1003 240035 0 240040 AJG511 11 17
54. 2013 4 11 230013 2 ME 2013 4 25 230018 PAH II 2013 4 5 230019 SAR245408 E CNV CNV 230012 GSK1605786A
55. 9E 230048 98 a Cabazitaxel yy DB yX 230048 BOB 230050 SK 1011 230052 TKI258 230054 DE 102 232001 ZD1839 232001 ZD1839 232001 ZD1839 232002 TAP 144 SR 3M 232003 FPF300 240002 256U87 240003 BAX111 BLB 200 240004 FK949E 240004 FK949E 240005 Z0188 8 240008 K 134 240009 TAP 144 SR 6M 240010 AJM300 240011 AK160 240011 AK160 240012 LFA102 240012 LFA102 240013 NIK 333 240013 NIK 333 240014 GP1101
56. 275 08 003 MTX CDP870 2013 4 3 26 CDP870 MTX 1 f E CDP870 MTX 275 08 003 E 2013 4 26 1 25 2013 4 210013 MTX CDP870
57. E VEGF Trap Eye ER 1 2013 4 4 230021 1 IPF BIBF 1120 150mg 1 2 52 2013 4 15 230021 2 IPF BIBF 1120 150mg 1
58. VEGF Trap Eye 1 I VEGF Trap Eye VEGF Trap Eye GSK1605786A
59. 13 4 4 220012 3 2013 4 16 220023 EB2080 2013 4 1 220024 1 BIBw2992 2013 4 12 220024 2 BIBW2992 DER
60. 9 Xx gt lt 7 gt PGI e 250011 0 c 2 1 4 f ee E hm FT 1 17
Download Pdf Manuals
Related Search
Related Contents
MetroVac 12-IDA32 Use and Care Manual Central Hydraulics Marine Instruments 94143 User's Manual turntable with mp3 player, usb/sd encoding function and remote Lightcommander 12 / 2 Manuel d`Utilisation Samsung Мікро аудіо система MM-D330D Керівництво користувача Cellular Line TRACCLIGHT Vac Pump RE3022C - Stuart Equipment 設定ツール取扱説明書 HTC 3G User's Manual Da-Lite Tensioned Dual Masking Electrol Copyright © All rights reserved.
Failed to retrieve file